awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37141237-9E401223-C8B3-45C3-8028-5B127670C517
Q37141237-9E401223-C8B3-45C3-8028-5B127670C517
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37141237-9E401223-C8B3-45C3-8028-5B127670C517
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.
P2860
Q37141237-9E401223-C8B3-45C3-8028-5B127670C517
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37141237-9E401223-C8B3-45C3-8028-5B127670C517
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
991a09e1befd471f7a91381b466a05a443aaf42b
P2860
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.